Primary analysis of a phase II open-label trial of INCB039110, a selective JAK1 inhibitor, in patients with myelofibrosis von Mascarenhas, John O, Talpaz, Moshe, Gupta, Vikas, Foltz, Lynda M, Savona, Michael R, Paquette, Ronald, Turner, A Robert, Coughlin, Paul, Winton, Elliott, Burn, Timothy C, O'Neill, Peter, Clark, Jason, Hunter, Deborah, Assad, Albert, Hoffman, Ronald, Verstovsek, Srdan

Volltext

Hodgkin's Lymphoma in Adolescents von FOLTZ, Lynda M, SONG, Kevin W, CONNORS, Joseph M

Volltext

Clinical Features, Treatment, and Outcome of HIV-Associated Immune Thrombocytopenia in the HAART Era von Ambler, Kimberley L. S., Vickars, Linda M., Leger, Chantal S., Foltz, Lynda M., Montaner, Julio S. G., Harris, Marianne, Lima, Viviane Dias, Leitch, Heather A.

Volltext

VEXAS syndrome: A review of bone marrow aspirate and biopsies reporting myeloid and erythroid precursor vacuolation von Cherniawsky, Hannah, Friedmann, Jordan, Nicolson, Hamish, Dehghan, Natasha, Stubbins, Ryan J., Foltz, Lynda M., Leitch, Heather A., Sreenivasan, Gayatri M., Ambler, Kimberley L. S., Nevill, Thomas J., McGinnis, Eric, Wilson, Lorena, Beck, David B., Chen, Luke Y. C., Marcon, Krista M.

Volltext

Recognition and management of methemoglobinemia and hemolysis in a G6PD‐deficient patient on experimental anticancer drug Triapine von Foltz, Lynda M., Dalal, Bakul I., Wadsworth, Louis D., Broady, Raewyn, Chi, Kim, Eisenhauer, Elizabeth, Kobayashi, Ken, Kollmannsburger, Christian

Volltext

Improved survival with iron chelation therapy for red blood cell transfusion dependent lower IPSS risk MDS may be more significant in patients with a non-RARS diagnosis von Leitch, Heather A, Chan, Christopher, Leger, Chantal S, Foltz, Lynda M, Ramadan, Khaled M, Vickars, Linda M

Volltext

Published guidelines versus real‐life practice in the diagnosis and treatment of essential thrombocythemia von Peterson, Erica A., Zypchen, Leslie, Lee, Vivian H. Y., Nitta, Janet, Foltz, Lynda M.

Volltext

Improved survival in red blood cell transfusion dependent patients with primary myelofibrosis (PMF) receiving iron chelation therapy von Leitch, Heather A., Chase, Jocelyn M., Goodman, Trisha A., Ezzat, Hatoon, Rollins, Meaghan D., Wong, Dominic H.C., Badawi, Maha, Leger, Chantal S., Ramadan, Khaled M., Barnett, Michael J., Foltz, Lynda M., Vickars, Linda M.

Volltext

Barriers To Diagnosis In Myeloproliferative Neoplasms von Yip, Raymond H L, Foltz, Lynda M

Volltext

Longitudinal and individual symptom analyses of momelotinib and ruxolitinib treated myelofibrosis patients from SIMPLIFY-1 von Mesa, Ruben A., Hudgens, Stacie, Floden, Lysbeth, Palmer, Jeanne, Gupta, Vikas, Mclornan, Donal P., McMullin, Mary Frances, Kiladjian, Jean-Jacques, Foltz, Lynda M., Platzbecker, Uwe, Fox, Maria Laura, Mead, Adam J., Ross, David M., Oh, Stephen T., Perkins, Andrew, Leahy, Michael F., Deheshi, Samineh, Donahue, Rafe, Klencke, Barbara J., Verstovsek, Srdan

Volltext

Ruxolitinib Overcomes the Adverse Prognostic Effect of Anemia in Patients with Myelofibrosis (MF) von Al-Ali, Haifa Kathrin, Stalbovskaya, Viktoriya, Gopalakrishna, Prashanth, Perez Ronco, Julian, Foltz, Lynda M

Volltext

PRM-151 in Myelofibrosis: Durable Efficacy and Safety at 72 Weeks von Verstovsek, Srdan, Mesa, Ruben A., Foltz, Lynda M, Gupta, Vikas, Mascarenhas, John O., Ritchie, Ellen K., Hoffman, Ronald, Silver, Richard T., Kremyanskaya, Marina, Pozdnyakova, Olga, Hasserjian, Robert P., Trehu, Elizabeth, Salama, Mohamed E, Kantarjian, Hagop M, Gotlib, Jason

Volltext

Phase 2 Trial of PRM-151, an Anti-Fibrotic Agent, in Patients with Myelofibrosis: Stage 1 Results von Verstovsek, Srdan, Mesa, Ruben A., Foltz, Lynda M, Gupta, Vikas, Mascarenhas, John O, Ritchie, Ellen K., Hoffman, Ronald, Silver, Richard T., Kremyanskaya, Marina, Pozdnyakova, Olga, Hasserjian, Robert P, Trehu, Elizabeth, Kantarjian, Hagop M., Gotlib, Jason R.

Volltext

Safety and Efficacy of Ruxolitinib in Patients with Low Platelets Enrolled in a Phase 3b Expanded-Access Study in Myelofibrosis (MF) von Griesshammer, Martin, Vannucchi, Alessandro M., le Coutre, Philipp, Tavares, Renato S, Al-Ali, Haifa Kathrin, Raanani, Pia, Gupta, Vikas, Foltz, Lynda M, Giraldo, Pilar, Bouard, Catherine, Perez Ronco, Julian, Ghosh, Jagannath, Martino, Bruno

Volltext

Safety and Efficacy of Ruxolitinib Retreatment after Treatment Interruption in Patients Enrolled in an Open-Label, Multicenter, Expanded-Access Study in Myelofibrosis von Gupta, Vikas, Tavares, Renato S, Griesshammer, Martin, Foltz, Lynda M, Raanani, Pia, Giraldo, Pilar, Al-Ali, Haifa Kathrin, Martino, Bruno, Tannir, Bayane, Ronco, Julian Perez, Ghosh, Jagannath, Vannucchi, Alessandro M.

Volltext

Primary Analysis Results from an Open-Label Phase II Study of INCB039110, a Selective JAK1 Inhibitor, in Patients with Myelofibrosis von Mascarenhas, John O, Talpaz, Moshe, Gupta, Vikas, Foltz, Lynda M, Savona, Michael R, Paquette, Ron, Turner, Robert, Coughlin, Paul, Winton, Elliott, Hunter, Deborah, Assad, Albert, Clark, Jason, O’Neill, Peter, Hoffman, Ronald, Verstovsek, Srdan

Volltext

Phase 2 trial of PRM-151, an antifibrotic agent, in patients with myelofibrosis: Stage 1 results von Verstovsek, Srdan, Mesa, Ruben A., Foltz, Lynda M., Gupta, Vikas, Mascarenhas, John, Ritchie, Ellen K., Hoffman, Ronald, Silver, Richard T., Hong, Wan-Jen, Kremyanskaya, Marina, Trehu, Elizabeth G., Kantarjian, Hagop M., Gotlib, Jason R.

Volltext

Improved Survival with Iron Chelation Therapy for Lower IPSS Risk MDS Appears to Have a Stronger Association in Patients with a Non-RARS Diagnosis von Leitch, Heather A, Chan, Christopher, Leger, Chantal S, Foltz, Lynda M, Ramadan, Khaled M, Vickars, Linda M

Volltext

Safety and Efficacy of Ruxolitinib in an Open-Label, Multicenter, Single-Arm, Expanded-Access Study in Patients with Myelofibrosis (MF): An 1144-Patient Update von Martino, Bruno, le Coutre, Philipp, Griesshammer, Martin, Illmer, Thomas, Schlag, Rudolf, Waller, Cornelius F., Liberati, Anna Marina, Schafhausen, Philippe, Tavares, Renato S, Vannucchi, Alessandro M., Giraldo, Pilar, Foltz, Lynda M, Raanani, Pia, Gupta, Vikas, Tannir, Bayane, Ronco, Julian Perez, Ghosh, Jaggannath, Al-Ali, Haifa Kathrin

Volltext

Diagnosis and Treatment of Essential Thrombocythemia: Assessment of Current Clinical Practice von Lee, Vivian H Y, Peterson, Erica, Zypchen, Leslie, Foltz, Lynda M

Volltext